---
figid: PMC6451240__13024_2019_314_Fig1_HTML
figtitle: Phagocytic pathway in glial cells
organisms:
- NA
pmcid: PMC6451240
filename: 13024_2019_314_Fig1_HTML.jpg
figlink: /pmc/articles/PMC6451240/figure/Fig1/
number: F1
caption: Phagocytic pathway in glial cells. Glial cell can recognize and uptake extracellular
  materials (targets) via specific receptors (receptor-target recognition). Targets
  are internalized and degraded through the endolysosomal machinery. Several PD-linked
  proteins intervene in the endolysosomal machinery and are highlighted in red
papertitle: Glial phagocytic clearance in Parkinsonâ€™s disease.
reftext: Marie-Eve Tremblay, et al. Mol Neurodegener. 2019;14:16.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9034777
figid_alias: PMC6451240__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6451240__F1
ndex: e78e24fd-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6451240__13024_2019_314_Fig1_HTML.html
  '@type': Dataset
  description: Phagocytic pathway in glial cells. Glial cell can recognize and uptake
    extracellular materials (targets) via specific receptors (receptor-target recognition).
    Targets are internalized and degraded through the endolysosomal machinery. Several
    PD-linked proteins intervene in the endolysosomal machinery and are highlighted
    in red
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DCSTAMP
  - ME1
  - MKS1
  - MCL1
  - C3
  - CXCR1
  - JMJD6
  - AXL
  - CD33
  - TREM2
  - GPER1
  - MERTK
  - TLR4
  - CX3CR1
  - MEGF10
  - CR1
  - CRIPTO
  - CCR1
  - RASD2
  - RAB10
  - RAB4A
  - RAB5A
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - VPS35
  - LRRK2
  - RAB7A
  - RAB7B
  - SYT11
  - SYT12
  - TG
  - MAP1LC3A
  - GBA1
  - GBA1LP
  - ATP13A2
  - Neurodegenerative disease
---
